Quick Answer
Palomino Laboratories Inc. reported Operating Income of -$2.70 million for fiscal year 2025.
Palomino Laboratories Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$2.70M | -44042.3% |
| 2024 | -$6.1K | +92.7% |
| 2023 | -$83.9K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.60M | -129958.5% | -4414.8% |
| June 30, 2025 | -$35.5K | -11.8% | +33.6% |
| March 31, 2025 | -$53.5K | -4.3% | -4237.5% |
| September 30, 2024 | -$1.2K | +97.1% | +96.1% |
| June 30, 2024 | -$31.8K | — | +38.0% |
| March 31, 2024 | -$51.3K | — | -19.7% |
| September 30, 2023 | -$42.9K | -908.5% | -908.5% |
| September 30, 2022 | -$4.2K | — | — |
- Palomino Laboratories Inc. showed a decrease of -44042.3% in Operating Income compared to the prior fiscal year.
- Over the 2023–2025 period, Palomino Laboratories Inc.’s operating income has declined by 3120.1% (from -$83.9 thousand to -$2.70 million).
- The most recent figure is from Palomino Laboratories Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: